What was the primary intent of the Bayh-Dole Act and the Stevenson-Wydler Technology Innovation Act?

Prepare for the Certified National Pharmaceutical Representative Exam. Utilize flashcards and multiple-choice questions, each with hints and explanations. Ace your exam!

The primary intent of the Bayh-Dole Act and the Stevenson-Wydler Technology Innovation Act was indeed to hasten the commercialization of technologies. These acts were designed to encourage the commercialization of inventions that arise from federally funded research. By allowing universities and small businesses to retain the rights to their inventions, these laws aim to foster innovation and expedite the translation of academic discoveries into marketable products and services.

The Bayh-Dole Act, enacted in 1980, specifically allows institutions to patent inventions developed with federal funding, facilitating partnerships between academic institutions and the private sector. Similarly, the Stevenson-Wydler Technology Innovation Act encourages federal laboratories to promote the commercialization of they develop through cooperation with the private sector. Both acts play a crucial role in bridging the gap between research and practical application, thereby stimulating economic growth and technological advancement.

In this context, protecting intellectual property rights, regulating pharmaceutical pricing, and promoting international research collaboration are also important issues but are not the central focus of these specific acts. The Bayh-Dole Act and its counterpart primarily emphasize speeding up the process by which new technologies can be developed into viable products that benefit society.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy